Annual Total Liabilities
$697.57 M
-$679.51 M-49.34%
December 31, 2023
Summary
- As of February 21, 2025, MRVI annual total liabilities is $697.57 million, with the most recent change of -$679.51 million (-49.34%) on December 31, 2023.
- During the last 3 years, MRVI annual total liabilities has fallen by -$418.38 million (-37.49%).
- MRVI annual total liabilities is now -49.34% below its all-time high of $1.38 billion, reached on December 31, 2022.
Performance
MRVI Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$665.09 M
-$6.11 M-0.91%
September 30, 2024
Summary
- As of February 21, 2025, MRVI quarterly total liabilities is $665.09 million, with the most recent change of -$6.11 million (-0.91%) on September 30, 2024.
- Over the past year, MRVI quarterly total liabilities has dropped by -$710.18 million (-51.64%).
- MRVI quarterly total liabilities is now -53.85% below its all-time high of $1.44 billion, reached on September 30, 2021.
Performance
MRVI Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MRVI Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -49.3% | -51.6% |
3 y3 years | -37.5% | -51.6% |
5 y5 years | +78.1% | -51.6% |
MRVI Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -49.3% | at low | -53.0% | at low |
5 y | 5-year | -49.3% | +61.0% | -53.9% | +53.5% |
alltime | all time | -49.3% | +78.1% | -53.9% | +53.5% |
Maravai LifeSciences Holdings Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $665.09 M(-0.9%) |
Jun 2024 | - | $671.19 M(+0.6%) |
Mar 2024 | - | $667.25 M(-4.3%) |
Dec 2023 | $697.57 M(-49.3%) | $697.57 M(-49.3%) |
Sep 2023 | - | $1.38 B(+0.6%) |
Jun 2023 | - | $1.37 B(-3.4%) |
Mar 2023 | - | $1.41 B(+2.7%) |
Dec 2022 | $1.38 B | $1.38 B(-2.1%) |
Sep 2022 | - | $1.41 B(+0.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $1.40 B(+0.7%) |
Mar 2022 | - | $1.39 B(+1.2%) |
Dec 2021 | $1.37 B(+23.0%) | $1.37 B(-4.7%) |
Sep 2021 | - | $1.44 B(+13.6%) |
Jun 2021 | - | $1.27 B(+11.0%) |
Mar 2021 | - | $1.14 B(+2.3%) |
Dec 2020 | $1.12 B(+157.6%) | $1.12 B(+58.9%) |
Sep 2020 | - | $702.12 M(+62.1%) |
Dec 2019 | $433.17 M(+10.6%) | $433.17 M |
Dec 2018 | $391.66 M | - |
FAQ
- What is Maravai LifeSciences Holdings annual total liabilities?
- What is the all time high annual total liabilities for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings annual total liabilities year-on-year change?
- What is Maravai LifeSciences Holdings quarterly total liabilities?
- What is the all time high quarterly total liabilities for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings quarterly total liabilities year-on-year change?
What is Maravai LifeSciences Holdings annual total liabilities?
The current annual total liabilities of MRVI is $697.57 M
What is the all time high annual total liabilities for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high annual total liabilities is $1.38 B
What is Maravai LifeSciences Holdings annual total liabilities year-on-year change?
Over the past year, MRVI annual total liabilities has changed by -$679.51 M (-49.34%)
What is Maravai LifeSciences Holdings quarterly total liabilities?
The current quarterly total liabilities of MRVI is $665.09 M
What is the all time high quarterly total liabilities for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high quarterly total liabilities is $1.44 B
What is Maravai LifeSciences Holdings quarterly total liabilities year-on-year change?
Over the past year, MRVI quarterly total liabilities has changed by -$710.18 M (-51.64%)